SEARCH

SEARCH BY CITATION

References

  • 1
    Else RW, Holmes JR. Pathological changes in atrial fibrillation in the horse. Equine Vet J 1971;3:5664.
  • 2
    Deem DA, Fregin GF. Atrial fibrillation in horses: A review of 106 clinical cases with consideration of prevalence, clinical signs, and prognosis. J Am Vet Med Assoc 1982;180:261265.
  • 3
    Reef VB, Levitan C, Spencer PA. Factors affecting prognosis and conversion in equine atrial fibrillation. J Vet Intern Med 1988;2:16.
  • 4
    Glendinning SA. The use of quinidine sulfate for the treatment of atrial fibrillation in twelve horses. Vet Rec 1965;77:951960.
  • 5
    Gerber H, Chuit P, Schatzmann HJ. Treatment of atrial fibrillation in the horse with intravenous dihydroquinidine gluconate. Equine Vet J 1971;3:110113.
  • 6
    Amada A, Kurita H. Treatment of atrial fibrillation with quinidine sulfate in the racehorse. Exp Rep Equine Health Lab 1978;15:4761.
  • 7
    Morris DD, Fregin GF. Atrial fibrillation in horses: Factors associated with response to quinidine sulfate in 77 clinical cases. Cornell Vet 1982;72:339349.
  • 8
    Muir WW, McGuirk SM. Hemodynamics before and after conversion of atrial fibrillation to normal sinus rhythm in horses. J Am Vet Med Assoc 1984;184:965970.
  • 9
    Muir WW, Reed SM, McGuirk SM. Treatment of atrial fibrillation in horses by intravenous administration of quinidine. J Am Vet Med Assoc 1990;197:16071610.
  • 10
    Reef VB, Reimer JM, Spencer PA. Treatment of atrial fibrillation in horses: New perspectives. J Vet Intern Med 1995;9:5767.
  • 11
    McGurrin MKJ, Physick-Sheard PW, Kenney DG, et al. Transvenous electrical cardioversion in equine atrial fibrillation: Technique and successful treatment of 3 horses. J Vet Intern Med 2003;17:715718.
  • 12
    McGurrin MKJ, Physick-Sheard PW, Kenney DG. How to perform transvenous electrical cardioversion in horses with atrial fibrillation. J Vet Cardiol 2005;7:109119.
  • 13
    McGurrin MKJ, Physick-Sheard PW, Kenney DG, et al. Transvenous electrical cardioversion of equine atrial fibrillation: Technical considerations. J Vet Intern Med 2005;19:695702.
  • 14
    De Clercq D, Van Loon G, Schauvliege S, et al. Transvenous electrical cardioversion of atrial fibrillation in six horses using custom made cardioversion catheters. Vet J 2008;177:198204.
  • 15
    Bellei MHM, Kerr C, McGurrin MKJ, et al. Management and complications of anesthesia for transvenous electrical cardioversion of atrial fibrillation in horses: 62 cases (2002–2006). J Am Vet Med Assoc 2007;231:12251230.
  • 16
    Pagel PS, Kehl F, Gare M, et al. Mechanical function of the left atrium: New insights based on analysis of pressure-volume relations and Doppler echocardiography. Anesthesiology 2003;82:151162.
  • 17
    Harjai KJ, Mobarek SK, Cheirif J, et al. Clinical variables affecting recovery of left atrial mechanical function after cardioversion from atrial fibrillation. J Am Coll Cardiol 1997;30:481486.
  • 18
    Schwarzwald CC, Schober KE, Bonagura JD. Echocardiographic evidence of left atrial mechanical dysfunction after conversion of atrial fibrillation to sinus rhythm in 5 horses. J Vet Intern Med 2007;21:820827.
  • 19
    Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined – a consensus document of the Joint European Society of Cardiology/ American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959969.
  • 20
    Babuin L, Jaffe AS. Troponin: The biomarker of choice for the detection of cardiac injury. Can Med Assoc J 2005;11911202.
  • 21
    Cornelisse CJ, Schott HC, Olivier NB, et al. Concentration of cardiac troponin I in a horse with a ruptured aortic regurgitation jet lesion and ventricular tachycardia. J Am Vet Med Assoc 2000;217:231235.
  • 22
    Schwarzwald CC, Hardy J, Buccellato M. High cardiac troponin I serum concentration in a horse with multiform ventricular tachycardia and myocardial necrosis. J Vet Intern Med 2003;17:364368.
  • 23
    Diana A, Guglielmini C, Candini D, et al. Cardiac arrhythmias associated with piroplasmosis in the horse: A case report. Vet J 2007;174:193195.
  • 24
    Divers TJ, Kraus MS, Jesty SA, et al. Clinical findings and serum cardiac troponin I concentrations in horses after intragastric administration of sodium monensin. J Vet Diagn Invest 2009;21:338343.
  • 25
    Kraus MS, Jesty SA, Gelzer AR. Measurement of equine cardiac troponin I utilizing a point of care analyzer in normal and experimentally diseased horses. Am J Vet Res 2009. In press.
  • 26
    Joglar JA, Kessler DJ, Welch PJ, et al. Effects of repeated electrical defibrillations on cardiac troponin I levels. Am J Cardiol 1999;83:270272.
  • 27
    Boriani G, Biffi M, Cervi V, et al. Evaluation of myocardial injury following repeated internal atrial shocks by monitoring serum cardiac troponin I levels. Chest 2000;118:342347.
  • 28
    Hedberg P, Valkama J, Suvanto E, et al. Evaluation of Innotrac Aio! Second generation cardiac troponin I assay: The main characteristics for routine clinical use. J Auto Methods Manag Chem 2006;2006:39325.
  • 29
    Di Serio F, Trerotoli P, Serio G, et al. Analytical evaluation of an automated immunoassay for cardiac troponin I: The Vidas troponin I assay. Clin Chem Lab Med 2003;41:13631368.
  • 30
    Pipers FS, Hamlin RL, Reef V. Echocardiographic detection of cardiovascular lesions in the horse. J Equine Med Surg 1979;3:6877.
  • 31
    Adams JE III, Schechtman KB, Landt Y, et al. Comparable detection of acute myocardial infarction by creatinine kinase MB isoenzyme and cardiac troponin I. Clin Chem 1994;40:12911295.
  • 32
    Koller A. Exercise-induced increases in cardiac troponins and prothrombotic markers. Med Sci Sports Exerc 2003;35:444448.
  • 33
    Yalcin R, Kaya MG, Ozdemir M, et al. Prospective randomized trial of transthoracic versus low-energy transvenous internal cardioversion in persistent atrial fibrillation. Acta Cardiol 2004;59:521526.
  • 34
    Gorenek B, Kudaiberdieva G, Goktekin O, et al. Detection of myocardial injury after internal cardioversion for atrial fibrillation. Can J Cardiol 2004;20:165168.
  • 35
    Boodhoo LE, Mitchell AR, O'Conner J, et al. Myocardial injury, neurohormonal activation and inflammation after internal atrial defibrillation. Int J Cardiol 2005;103:6772.
  • 36
    Simon C, Roscitano A, Capuano F, et al. Effect of topic defibrillation on serum markers of myocardial damage. Interact Cardiovasc Thorac Surg 2006;5:7577.
  • 37
    O'Brien PJ, Landt Y, Ladenson JH. Differential reactivity of cardiac and skeletal muscle from various species in a cardiac troponin I immunoassay. Clin Chem 1997;43:23332338.
  • 38
    Begg LM, Hoffmann, Begg AP. Serum and plasma cardiac troponin I concentrations in clinically normal Thoroughbreds in training in Australia. Aust Vet J 2006;84:336337.
  • 39
    Phillips W, Giguere S, Franklin RP, et al. Cardiac troponin I in pastured and race-training Thoroughbred horses. J Vet Intern Med 2003;17:597599.
  • 40
    Mair J, Wagner I, Morass B, et al. Cardiac troponin I release correlates with myocardial infarction size. Eur J Clin Chem Clin Biochem 1995;33:869872.